LESLIE DAILEY: Open Payments
NPI 1548606742 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 19 payments from 9 companies in 2025. Trend: 2023 $251 · 2024 $671 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $161 |
| AKEBIA THERAPEUTICS INC | 4 | $108 |
| Novo Nordisk Inc | 2 | $48 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Haemonetics Corporation | 1 | $25 |
| Calliditas Therapeutics US Inc. | 1 | $23 |
| ABIOMED | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: JARDIANCE, Vafseo, Auryxia, Ozempic, TEG5000 HEMOSTASIS ANALYZER, TARPEYO, Kerendia, TAVNEOS.
Industry payments across AL — which companies pay providers there.
